First Longevity announces first investors for current round

Some news of our own: European VC fund and a Longevity innovator participate in the First Longevity funding round.

Last week we announced that Tom Britton joined our Advisory Panel as plans for our Longevity equity funding platform take another step forward. Today we’re pleased to announce a six-figure investment in our current funding round for First Longevity. We are now putting our new investors’ cash to work whilst still keeping our funding round open; enabling us to get on with our plans as this sector is growing fast – and we don’t like to drag our heels!

Among those participating in this first stage are Chairman, George Sutherland and a new European Longevity-focused fund based in the Czech Republic. Petr Sramek (pictured), Co-founder, Chairman and Managing Partner of, commented: “Success is a function of perfect timing, strategic position, and the team. These are exactly the ingredients we like about the First Longevity business plan.”


“There is exceptional progress in the science of understanding aging and at the same time it is also probably the world’s greatest and most ethical investment opportunity.” has already invested in another UK business, Agecurve, and with more investors entering the Longevity sector, we were interested in understanding the indicators that Petr is experiencing to demonstrate growth of the Longevity market, he told us: “There is exceptional progress in the science of understanding aging and at the same time it is also probably the world’s greatest and most ethical investment opportunity.”

George Sutherland, Chairman of First Longevity Ltd, commented: “It’s great to have Petr and his fund as an early investor and together with myself and another key investor who’s well-known in the Longevity field, we are making important steps forward while we continue with the round. While we do have commitment from other key Longevity investors, we would welcome the opportunity to chat with others who may be interested in the round.

First Longevity Ltd has been formed to capitalise on the growing Longevity opportunity. This news platform launched in September 2019 and delivers daily news and insights to a growing international audience of investors, start-ups, academics and consumers. The next stage of our plan is a digital equity fundraising platform, Crowd Longevity, which will present pre-screened Longevity tech businesses to our growing investor community.

We recently announced the appointment of our Advisory Panel of leading experts from Longevity science and investment: the Board and the Advisory Panel will support the development of unique media content while reviewing the scientific, technical and investment potential of companies presented to equity investors.

Thanks to you for your ongoing interest and advocacy!

Phil Newman
Editor-in-Chief Phil is Editor-in-Chief Longevity.Technology and founder of Crowd Longevity a digital investment platform for international investors and Longevity start-ups launching in 2020.

In his career, Phil has held c-level management positions; applying his marketing and business development expertise into these tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.

Latest articles

AI app reveals your biological age – and how to slow it down

Only as old as you feel ... or only as old as your Young.AI app tells you? We use our phones for just about everything...

Psychobiome: trusting your gut for Longevity

Scientists studying how the microbiome affects our mood aim to develop gut microbiome-modulating formulations to treat depression and other brain diseases. Recent work from Katya...

Startup Showcase: Jinfiniti: What do you think?

Comprehensive biomarker tech: Invest, buy, or both? It's time to have your say on Jinfiniti. We like what Jinfiniti are doing; but that's just our...

When AI means artificial immortality: just ask Alexa

Hereafter is turning dead ends into conversational opportunities. Understandably, we use Longevity in a mostly physical sense - extending lifespan and healthspan and combating aging...